June 26, 2023
GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants
Read More
June 20, 2023
GeneDx Commends the States of Arizona and Florida for Adding Rapid Whole Genome Sequencing (rWGS) as a Covered Benefit for Medicaid Pediatric Patients
Read More
May 24, 2023
GeneDx to Participate in Upcoming Investor Conferences in June
Read More
May 23, 2023
GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations
Read More
May 22, 2023
GeneDx Regains Compliance with Nasdaq Minimum Bid Price Requirement
Read More
May 9, 2023
GeneDx Reports First Quarter 2023 Financial Results and Business Highlights
Read More
May 4, 2023
GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option
Read More
May 3, 2023
GeneDx Announces Clarification Regarding CUSIP Number for Public Warrant Holders
Read More
April 28, 2023
GeneDx Announces Reverse Stock Split
Read More
April 18, 2023
GeneDx to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
Read More
Displaying 11 - 20 of 33